Advertisement

Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up

  • Enrico GranieriEmail author
  • Nico Golfrè Andreasi
  • Paolo De Martin
  • Vittorio Govoni
  • Massimiliano Castellazzi
  • Edward Cesnik
  • Maura Pugliatti
  • Ilaria Casetta
Original Article
  • 23 Downloads

Abstract

Background

Guillain-Barré syndrome (GBS) is an acute/subacute autoimmune inflammatory polyradiculoneuropathy. Previous epidemiological studies carried out in the province of Ferrara, Italy, from 1981 to 2002 indicated that GBS incidence had tendency of increase in the period considered.

Objectives

We aimed at updating the epidemiology of GBS in the years 2003–2017 and carrying on the work started in the 1980s.

Methods

We conducted an incidence study, by adopting a complete enumeration approach. Cases were identified from administrative, medical records, and database of the Ferrara Hospital and other provincial structures of the study area. Case ascertainment and definition are analogous to those adopted in previous surveys.

Results

In the period 1 January 2003 to 31 December 2017, 73 patients living in the province of Ferrara (mean population 353,142) were found to be new cases of GBS fulfilling the NINCDS criteria. Male/female ratio 1.15. The mean incidence rate was 1.38 per 100,000 (95% CI 1.08–1.74), 1.54 per 100,000 for men and 1.23 per 100,000 for women, a nonsignificant difference. During the period considered, the rates had slow increase or mild decrease, without nonsignificant difference. The highest rates were observed for the age groups 70–79 years for both sexes. A half of patients reported infectious events in the weeks before the onset of symptoms.

Conclusion

In line with many epidemiological data, in the whole period 2003–2017, we observed a trend towards increase or decrease in incidence and periods of relative stability. Similar temporal heterogeneity with the comparison to our previous works was found.

Keywords

Guillain-Barré syndrome Epidemiology Incidence Ferrara Italy 

Notes

Acknowledgements

The authors thank Dr. Eva Sjolin for her the help in revising the translation of the text.

Funding information

This work is supported by Ferrara University (Fondo di Ateneo per la Ricerca).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Ethics approval for the study was obtained.

References

  1. 1.
    Hughes RA, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366:1653–1666CrossRefGoogle Scholar
  2. 2.
    Hardy TA, Blum S, McCombe PA, Reddel SW (2011) Guillain-Barré syndrome: modern theories of etiology. Curr Allergy Asthma Rep 11:197–204CrossRefGoogle Scholar
  3. 3.
    Cosi V, Versino M (2006) Guillain-Barré syndrome. Neurol Sci 27:S47–S51CrossRefGoogle Scholar
  4. 4.
    Fujimura H (2013) The Guillain-Barré syndrome. In Said G, Krarup C (eds): Peripheral nerve disorders. In Aminoff MJ, Boller F, Swaab D (series eds): Handbook of clinical neurology Edinburgh London New York Oxford Philadelphia St Louis Sidney Toronto, Elsevier BV, vol 115 (3rd series), 383-402Google Scholar
  5. 5.
    Olivé JM, Castillo C, Garcia Castro R, de Quadros CA (1997) Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis 175:160–164CrossRefGoogle Scholar
  6. 6.
    Govoni V, Granieri E (2001) Epidemiology of Guillain-Barré syndrome. Curr Op Neurol 14:605–613CrossRefGoogle Scholar
  7. 7.
    Paolino E, Govoni V, Tola MR, Casetta I, Granieri E (1991) Incidence of the Guillain-Barré syndrome in Ferrara, Northern Italy, 1981–1987. Neuroepidemiology 10:105–111CrossRefGoogle Scholar
  8. 8.
    Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC (1996) The incidence of Guillain-Barré syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 137:62–68CrossRefGoogle Scholar
  9. 9.
    Govoni V, Granieri G, Manconi M, Capone J, Casetta I (2003) Is there a decrease in Guillain–Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci 15(216):99–103CrossRefGoogle Scholar
  10. 10.
    Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl):S21–S24CrossRefGoogle Scholar
  11. 11.
    Italian National Institute of Statistics Population Census. http://daticensimentopopolazione.istat.it/Index.aspx?lang=en. 2012, 2011; Accessed 30 Sept 2015
  12. 12.
    Waterhouse JAH, Muir CS, Correa P, Powell J (1976) Cancer incidence in five continents. Lyon, IARC 3: 456Google Scholar
  13. 13.
    Schoenberg BS (1983) Calculating confidence intervals for rates and ratios: simplified methods utilizing tabular values based in the Poisson distribution. Neuroepidemiology 2:257–265CrossRefGoogle Scholar
  14. 14.
    Benedetti MD, Pugliatti M, D’ Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Galeotti F, Massari M, Santuccio C, Raschetti R, ITANG Study Group (2015) A multicentric prospective incidence study of Guillain-Barré syndrome in Italy. The ITANG Study. Neuroepidemiology 45:90–99CrossRefGoogle Scholar
  15. 15.
    Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillán CA, Díaz M, Duarte J, Fernández MD, Fernandez O, García-López F, García-Merino A, Velasquez JM, Martínez-Matos JA, Palomo F, Pardo J, Tobías A for the Spanish GBS Epidemiological Study Group (2004) Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci 25:57–65CrossRefGoogle Scholar
  16. 16.
    Mc Grogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barré syndrome worldwide: a systemic literature review. Neuroepidemiology 32:150–163CrossRefGoogle Scholar
  17. 17.
    Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123–133CrossRefGoogle Scholar
  18. 18.
    Hense S, Schink T, Kreisel SH, Marcelon L, Simondon F, Tahden M, Garbe E (2014) Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology 43:244–252CrossRefGoogle Scholar
  19. 19.
    Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A (2017) Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). J Peripher Nerv Syst 22:51–58CrossRefGoogle Scholar
  20. 20.
    Cheng Q, Jiang GX, Fredrikson S, Link H, De Pedro-Cuesta J (2000) Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 7:11–16CrossRefGoogle Scholar
  21. 21.
    Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meché FG (2000) Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625CrossRefGoogle Scholar
  22. 22.
    Aladro-Benito Y, Conde-Sendin MA, Muñoz-Fernández C, Pérez-Correa S, Alemany-Rodríguez MJ, Fiuza-Pérez MD, Alamo-Santana F (2002) Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote. Rev Neurol 35:705–710PubMedGoogle Scholar
  23. 23.
    Huges RA, Charlton J, Latinovic R, Gulliford MC (2006) No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 166:1301–1304CrossRefGoogle Scholar
  24. 24.
    Sipilä JOT, Soilu-Hänninen M, Ruuskanen JO, Rautava P, Kytö V (2017) Epidemiology of Guillain-Barré syndrome in Finland 2004–2014. J Peripher Nerv Syst 22:440–445CrossRefGoogle Scholar
  25. 25.
    Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL (1991) The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 30:618–621CrossRefGoogle Scholar
  26. 26.
    Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK, Vaccine Safety Datalink Research Team (2012) Guillain-Barré syndrome incidence in a large United States cohort (2000–2009). Neuroepidemiology 39:109–115CrossRefGoogle Scholar
  27. 27.
    Blum S, Reddel S, Spies J, McCombe P (2013) Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia. J Peripher Nerv Syst 18:316–320CrossRefGoogle Scholar
  28. 28.
    Chen Y, Ma F, Zhang J, Chu X, Hu Y (2014) Population incidence of Guillain-Barré syndrome in parts of China: three large populations in Jiangsu province, 2008–2010. Eur J Neurol 21:124–129CrossRefGoogle Scholar
  29. 29.
    Yoshikawa H (2015) Epidemiology of Guillain-Barré syndrome. Brain Nerve 67:1305–1311PubMedGoogle Scholar
  30. 30.
    Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J; Spanish GBS Epidemiology Study Group (2016) Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge. BMC Neurol 16:75Google Scholar
  31. 31.
    Incecik F, Hergüner O M, Altunbasak S (2011) Guillain–Barré syndrome in children. Neurol Sci (2011) 32:381–385Google Scholar
  32. 32.
    Guillain Barrè Study Group (2000) Guillain Barré syndrome: an Italian multicentre case-control study. Neurol Sci 21:229–234CrossRefGoogle Scholar
  33. 33.
    Tam CC, O’Brien SJ, Peterson I, Islam A, Hayward A, Rodrigues LC (2007) Guillain Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2(4):e344CrossRefGoogle Scholar
  34. 34.
    Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR (2015) Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry 86:1196–1201CrossRefGoogle Scholar
  35. 35.
    Galeotti F, Massari M, D’Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R, The ITANG study group (2013) Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol 28:433–444CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Department of Biomedical and Specialty-Surgical Sciences, Section of Neurology, Psychology and PsychiatryUniversity of FerraraConaItaly

Personalised recommendations